Financial Statements

Bio-Rad Laboratories, Inc. (BIO)


-12.53 (-2.47%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 9,2685,4713,7221,830-
Net Income 4,2463,8061,759366122
Stock Dividends -7-9-101,5261,708
Dividend Paid -----
Retained Earnings 13,5079,2685,4713,7221,830

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 694701509493-
Annual Depreciation 12391291145609
Capital Expenditure -121-99-99-130-115
Net PPE 696694701509493

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -506220224292
New Purchases -283-371-451-345-1,305
Intangible and Goodwill 506220224292347

Bio-Rad Laboratories, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Bio-Rad Laboratories, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.